Science Explorer Back to mapMap
Discussion

Verax Biomedical (United States)

Research works
37
▼ 69% vs 2018-21
Citations
479
13.0 per fractional work
Top-10% rate
7.1%
all institutions 10.0%
Open access
25%
world 40%
International
12%
world 18%

Not ranked overall: Verax Biomedical (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Verax Biomedical (United States) work in?

In all years, 34% of research at Verax Biomedical (United States) is in Life Sciences, 27% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (34%), Medicine (25%), Engineering (17%). It does 1.8× the world's share of Life Sciences.

Life Sciences: 12 fractional works · 33.9% of its workBiochemistry, Genetics and Molecular Biology: 12 fractional works · 33.6% of its workMolecular Biology: 9 fractional works · 24.7% of its workGenetics: 1 fractional works · 3.2% of its workBiotechnology: 1 fractional works · 1.8% of its workEndocrinology: 1 fractional works · 1.8% of its workClinical Biochemistry: 0 fractional works · 0.9% of its workMolecular Medicine: 0 fractional works · 0.9% of its workBiochemistry: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 0.3% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workHealth Sciences: 10 fractional works · 27.2% of its workMedicine: 9 fractional works · 25.4% of its workBiochemistry: 2 fractional works · 5.2% of its workSurgery: 2 fractional works · 4.2% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 2.7% of its workEpidemiology: 1 fractional works · 2.5% of its workImmunology and Allergy: 1 fractional works · 1.8% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.6% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 1.4% of its workPhysiology: 0 fractional works · 1.1% of its workDermatology: 0 fractional works · 0.9% of its workNephrology: 0 fractional works · 0.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.9% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.3% of its workGenetics: 0 fractional works · 0.3% of its workRehabilitation: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.7% of its workDentistry: 0 fractional works · 0.9% of its workPeriodontics: 0 fractional works · 0.9% of its workHealth Professions: 0 fractional works · 0.9% of its workEmergency Medical Services: 0 fractional works · 0.9% of its workPhysical Sciences: 10 fractional works · 27.1% of its workEngineering: 6 fractional works · 16.8% of its workBiomedical Engineering: 4 fractional works · 11.1% of its workElectrical and Electronic Engineering: 1 fractional works · 1.8% of its workMedia Technology: 0 fractional works · 1.4% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 1.1% of its workCivil and Structural Engineering: 0 fractional works · 0.5% of its workMechanical Engineering: 0 fractional works · 0.5% of its workMechanics of Materials: 0 fractional works · 0.5% of its workComputer Science: 3 fractional works · 8.5% of its workArtificial Intelligence: 2 fractional works · 5.4% of its workInformation Systems: 1 fractional works · 2.4% of its workComputer Networks and Communications: 0 fractional works · 0.6% of its workEarth and Planetary Sciences: 0 fractional works · 0.9% of its workPaleontology: 0 fractional works · 0.9% of its workChemistry: 0 fractional works · 0.5% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.5% of its workEnvironmental Science: 0 fractional works · 0.5% of its workEcology: 0 fractional works · 0.5% of its workSocial Sciences: 4 fractional works · 11.8% of its workBusiness, Management and Accounting: 2 fractional works · 4.5% of its workManagement of Technology and Innovation: 1 fractional works · 3.4% of its workStrategy and Management: 0 fractional works · 1.1% of its workSocial Sciences: 1 fractional works · 3.8% of its workCultural Studies: 1 fractional works · 1.8% of its workSociology and Political Science: 0 fractional works · 1.2% of its workAnthropology: 0 fractional works · 0.3% of its workPolitical Science and International Relations: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workArts and Humanities: 1 fractional works · 1.8% of its workArcheology: 1 fractional works · 1.8% of its workDecision Sciences: 0 fractional works · 0.9% of its workInformation Systems and Management: 0 fractional works · 0.9% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.8% of its workGeneral Economics, Econometrics and Finance: 0 fractional works · 0.5% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workALL ITS WORKVerax Biomedical(United States)37fractional works, all years
Life Sciences34%Physical Sciences27%Health Sciences27%Social Sciences12%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1233.6%
    2. Neuroscience00.3%
    1. Medicine925.4%
    2. Dentistry00.9%
    3. Health Professions00.9%
    1. Engineering616.8%
    2. Computer Science38.5%
    3. Earth and Planetary Sciences00.9%
    4. Chemistry00.5%
    5. Environmental Science00.5%
    1. Business, Management and Accounting24.5%
    2. Social Sciences13.8%
    3. Arts and Humanities11.8%
    4. Decision Sciences00.9%
    5. Economics, Econometrics and Finance00.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.53× its world share, 0 worksBiochemistry, Geneti…Neuroscience: 1.14× its world share, 0 worksNeuroscienceComputer Science: 6.40× its world share, 3 worksComputer ScienceMedicine: 1.68× its world share, 2 worksMedicineDecision Sciences: 5.72× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.03× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.44× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Computer Science, 6.4×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Computer Science6.40×3 works
  2. Decision Sciences5.72×0 works
  3. Medicine1.68×2 works
  4. Neuroscience1.14×0 works
  5. Economics, Econometrics and Finance1.03×0 works
  6. Biochemistry, Genetics and Molecular Biology0.53×0 works
  7. Social Sciences0.44×0 works

Who are the top researchers at Verax Biomedical (United States)?

Ranked on the quality score, Remo P. Vallejo lead among researchers whose main affiliation is Verax Biomedical (United States).

  1. 1 Remo P. Vallejo United States · #2,387,791 worldwide 532 citations · 17 works
All ranked researchers at Verax Biomedical (United States)

What are the most cited papers from Verax Biomedical (United States)?

The most cited paper from Verax Biomedical (United States) is "Review of current transfusion therapy and blood banking practices" (Emily K. Storch, Brian Custer, Michael R. Jacobs et al., 2019), with 100 citations. Next come "Cultivation of hybridoma cells in continuous cultures: Kinetics of growth and product formation" (81) and "Large‐Scale Culture of Hybridoma and Mammalian Cells in Fluidized Bed Bioreactors" (45).

Most cited papers
#PaperReleasedCitations
1 Review of current transfusion therapy and blood banking practices Emily K. Storch, Brian Custer, Michael R. Jacobs et al. · Blood Reviews 25 Jul 2019 100
2 Cultivation of hybridoma cells in continuous cultures: Kinetics of growth and product formation N. G. Ray, Subhash B. Karkare, P. W. Runstadler · Biotechnology and Bioengineering 5 Feb 1989 81
3 Large‐Scale Culture of Hybridoma and Mammalian Cells in Fluidized Bed Bioreactors Robert C. Dean, SABHASH B. KARKARE, N. G. Ray et al. · Annals of the New York Academy of Sciences Nov 1987 45
4 Optimization of Mammalian–Cell Bioreactors Michael W. Young, Robert C. Dean · Nature Biotechnology Aug 1987 37
5 The influence of dissolved oxygen tension on the metabolic activity of an immobilized hybridoma population J. Th�mmes, J. G�tgens, Manfred Biselli et al. · Cytotechnology 1993 32
All 55 most cited papers, with filters and sorting

Which keywords describe research at Verax Biomedical (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cell Culture, Biopharmaceutical Production, Glycosylation, Mammalian Cells, Recombinant Protein, Blood Transfusion, Biopharmaceuticals and Therapeutic Antibodies.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 35 words, with their numbers
  1. Cell Culture7▲ 168×2 topics
  2. Biopharmaceutical Production5▲ 175×2 topics
  3. Glycosylation5▲ 58×2 topics
  4. Mammalian Cells4▲ 302×1 topic
  5. Recombinant Protein4▲ 302×1 topic
  6. Blood Transfusion3▲ 159×2 topics
  7. Biopharmaceuticals3▲ 119×2 topics
  8. Therapeutic Antibodies3▲ 64×2 topics
  9. Protein Aggregation3▲ 92×1 topic
  10. Stability3▲ 38×1 topic
  11. Regenerative Medicine2▲ 32×2 topics
  12. Bioprinting2▲ 145×1 topic
  13. Hemorrhage2▲ 90×2 topics
  14. Tissue Engineering2▲ 12×1 topic
  15. Risk Factors2▲ 5.5×4 topics
  16. Anemia2▲ 45×1 topic
  17. Critical Care2▲ 24×2 topics
  18. Tranexamic Acid2▲ 249×1 topic
  19. Inflammation2▲ 2.1×8 topics
  20. Machine Learning2▲ 2.2×3 topics
  21. Security2▲ 11×3 topics
  22. Supply Chain Management2▲ 8.8×2 topics
  23. Diabetes Mellitus2▲ 18×4 topics
  24. Globalization1▲ 1.97×4 topics
  25. Blood Donation1▲ 227×1 topic
  26. Donor Behavior1▲ 227×1 topic
  27. Epidemiology1▼ 0.82×5 topics
  28. Heart Failure1▲ 6.9×4 topics
  29. Adversarial Examples1▲ 156×1 topic
  30. Cardiovascular Disease1▲ 2.5×6 topics
  31. Deep Learning1▲ 1.29×1 topic
  32. Gene Expression1▲ 4.5×2 topics
  33. Genomic Integration1▲ 26×2 topics
  34. Pancreatic Islets1▲ 41×1 topic
  35. ß-Cell Dysfunction1▲ 41×1 topic

Which research topics does Verax Biomedical (United States) publish most on?

By volume in 2022-now: Adversarial Robustness in Machine Learning, Digital and Cyber Forensics, Privacy-Preserving Technologies in Data and Security and Verification in Computing.

  1. 1 Adversarial Robustness in Machine Learning Artificial Intelligence 1 works
  2. 2 Digital and Cyber Forensics Information Systems 1 works
  3. 3 Privacy-Preserving Technologies in Data Artificial Intelligence 1 works
  4. 4 Security and Verification in Computing Artificial Intelligence 0 works
  5. 5 Scientific Computing and Data Management Information Systems and Management 0 works
  6. 6 Retinal and Macular Surgery Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Digital Imaging in Medicine Public Health, Environmental and Occupational Health 0 works
  8. 8 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
  9. 9 Nutrition and Health in Aging Physiology 0 works
  10. 10 Software System Performance and Reliability Computer Networks and Communications 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available25.3%not open74.7%

World: 40% of research is openly available.

with international co-authors11.7%domestic only88.3%

World: 18% is written across borders.

How has Verax Biomedical (United States)'s research output changed?

Output in 2022-2025 was 69% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Verax Biomedical (United States) as a percentage of every work published that year, 0.000015% in 2024.

still counting0.00025%0.00050%0.00075%Verax Biomedical (United States)0.0000056% in 20251990200020102020

Fractional works of Verax Biomedical (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Marlborough

All research institutions in Marlborough

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Verax Biomedical (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.